Search

everythinglearnresearchcommunity

for

Search:↓

GLP-1RA therapy may increase the risk of hair loss.

GLP-1 receptor agonists for weight loss may cause hair loss, especially in women.

GLP-1 agonists may increase the risk of hair loss.

GLP1-RAs may have higher reports of suicide and hair loss, but no strong evidence links them to these issues.

Newer GLP-1 drugs like semaglutide may cause hair loss.

GLP-1 receptor agonists help women with PCOS lose weight and improve health, but more research is needed on long-term effects.

GLP-1RAs, like semaglutide and tirzepatide, may cause hair loss, so patients should be informed and monitored.

GLP-1 receptor agonists may cause hair loss, but regrowth is rare.

GLP-1 therapies, especially semaglutide and tirzepatide, may cause hair loss, particularly in women and with rapid weight loss.

Medications for PCOS don't seem to raise heart disease risk.

SGLT2 inhibitors may help manage PCOS symptoms effectively.

Effective weight loss during pregnancy is crucial for better maternal and fetal health.

PCOS treatment should be personalized based on individual symptoms and health goals.

Methylene blue helps hair growth by protecting hair stem cells from stress.

5-alpha reductase inhibitors and spironolactone don't increase gynecological tumor risk, glucagon-like-peptide-1 receptor agonists may increase alopecia risk, sanitary pads can cause dermatitis, early hidradenitis suppurativa intervention is crucial for Hispanic patients, community education boosts skin cancer awareness, metformin may improve skin cancer survival, LNG-IUDs can increase acne risk, machine learning accurately detects basal cell carcinoma, JAK-inhibitors may raise miscarriage risk, inclusive skincare ads affect those with darker skin, and CCCA in Black women might involve autoimmunity.

Metabolic issues may trigger lymphocytic cicatricial alopecia, and treatments targeting these issues could help.

GLP-1 receptor agonists can both help and harm hair, so careful monitoring is needed.

GLP-1 receptor agonists can cause skin reactions, facial fat loss, and hair loss, but may help with wound healing and skin conditions.

New therapies for rare skin diseases show promise but need more research.

Combining lifestyle changes and medication is most effective for managing PCOS symptoms.

SARS-CoV-2, the virus causing COVID-19, can affect all endocrine organs and systems, altering their function and potentially leading to disorders. Factors like diabetes and obesity increase infection risk and severity. Understanding these effects is key for effective treatment.

GLP-1 receptor agonists may help or harm hair health, needing more research.

Combining antidiabetic drugs, hormonal therapies, and lifestyle changes can improve health in women with PCOS.

GLP-1 receptor agonists may help manage and prevent diabetic foot ulcers.

The Polish medical societies have redefined metabolic syndrome and recommend lifestyle changes, certain medications, and possibly bariatric surgery for treatment. They also discuss managing related health conditions.

Peptide-based hydrogels are promising for healing chronic wounds effectively.

Researchers found genes that may explain why some pigs grow winter hair, which could help breed cold-resistant pigs.

New guidelines stress early diagnosis and lifestyle changes to manage metabolic syndrome and prevent complications.

Hair loss from weight-loss treatments is usually temporary and reversible.